Live price temporarily unavailable.
Cardlytics (CDLX) is a Information Technology company. Latest news and coverage below.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $112.8M | $130.4M | $150.7M | $210.4M | $186.9M | $267.1M | $298.5M | $309.2M | $278.3M | $233.3M |
| Growth (year over year) | — | +15.6% | +15.6% | +39.6% | −11.2% | +42.9% | +11.8% | +3.6% | −10.0% | −16.2% |
| Operating income | −$56.2M | −$17.1M | −$40.9M | −$17.3M | −$53.9M | −$122.6M | −$457.8M | −$135.7M | −$195.5M | −$101.8M |
| Operating margin | −49.8% | −13.1% | −27.2% | −8.2% | −28.9% | −45.9% | −153.3% | −43.9% | −70.2% | −43.6% |
| Net income | −$75.7M | −$19.6M | −$53.0M | −$17.1M | −$55.4M | −$128.6M | −$465.3M | −$134.7M | −$189.3M | −$103.5M |
| Net margin | −67.1% | −15.1% | −35.2% | −8.1% | −29.7% | −48.1% | −155.8% | −43.6% | −68.0% | −44.4% |
| EPS (diluted) | −$32.48 | −$7.86 | −$2.79 | −$0.72 | −$2.04 | −$3.99 | −$13.92 | −$3.69 | −$3.91 | −$1.95 |
| Balance sheet | ||||||||||
| Cash and equivalents | $22.8M | $21.3M | $39.6M | $104.5M | $293.2M | $233.5M | $121.9M | $91.8M | $65.6M | $48.7M |
| Total assets | — | $100.8M | $153.8M | $224.3M | $422.5M | $1.26B | $691.2M | $574.1M | $392.7M | $285.6M |
| Total liabilities | — | $309.4M | $101.8M | $81.0M | $265.3M | $573.1M | $479.6M | $439.3M | $322.7M | $292.1M |
| Long-term debt | — | $57.0M | $46.7M | $13.0K | $174.0M | $184.4M | $226.0M | $257.5M | $213.6M | $208.9M |
| Shareholders' equity | −$216.8M | −$208.7M | $52.0M | $143.3M | $157.2M | $690.7M | $211.6M | $134.8M | $70.0M | −$6.51M |
| Cash flow | ||||||||||
| Operating cash flow | −$32.5M | −$22.1M | −$19.0M | $11.5M | −$7.60M | −$38.5M | −$53.9M | −$185.0K | −$8.82M | $9.29M |
| Capital expenditure | $1.83M | $1.22M | $5.92M | $8.28M | $5.41M | $3.11M | $1.17M | $667.0K | $1.56M | $480.0K |
| Free cash flow | −$34.3M | −$23.3M | −$24.9M | $3.18M | −$13.0M | −$41.6M | −$55.1M | −$852.0K | −$10.4M | $8.81M |
| Share buybacks | — | — | — | — | $0 | $0 | $40.0M | $0 | $0 | — |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $67.1M | $74.0M | $56.4M | $58.0M | $52.0M | $66.8M | $34.3M | $36.9M |
| Growth (year over year) | −15.1% | −17.0% | −16.5% | −16.7% | −22.4% | −9.8% | −39.2% | −36.5% |
| Operating income | −$148.5M | −$8.31M | −$11.1M | −$9.57M | −$68.9M | −$12.3M | −$8.27M | −$5.44M |
| Operating margin | −221.5% | −11.2% | −19.7% | −16.5% | −132.3% | −18.4% | −24.1% | −14.8% |
| Net income | −$145.2M | −$15.6M | −$13.3M | −$9.28M | −$72.7M | −$8.25M | −$4.48M | −$14.9M |
| Net margin | −216.5% | −21.1% | −23.5% | −16.0% | −139.7% | −12.4% | −13.1% | −40.3% |
| EPS (diluted) | −$2.90 | −$0.36 | −$0.26 | −$0.18 | −$1.36 | −$0.15 | — | — |
| Balance sheet | ||||||||
| Cash and equivalents | $67.0M | $65.6M | $52.0M | $46.7M | $44.0M | $48.7M | $35.7M | $28.0M |
| Total assets | $399.4M | $392.7M | $369.1M | $361.1M | $292.8M | $285.6M | $263.9M | $234.8M |
| Total liabilities | $329.7M | $322.7M | $305.0M | $302.4M | $297.5M | $292.1M | $267.9M | $250.8M |
| Long-term debt | $213.2M | $213.6M | $213.9M | $214.3M | $214.6M | $208.9M | $204.2M | $184.4M |
| Shareholders' equity | $69.7M | $70.0M | $64.1M | $58.7M | −$4.70M | −$6.51M | −$4.00M | −$16.0M |
| Cash flow | ||||||||
| Operating cash flow | $1.39M | $2.98M | −$6.71M | $1.23M | $1.76M | $13.0M | −$5.64M | −$8.60M |
| Capital expenditure | $507.0K | $123.0K | $119.0K | $322.0K | $14.0K | $25.0K | $28.0K | $2.00K |
| Free cash flow | $878.0K | $2.86M | −$6.83M | $903.0K | $1.75M | $13.0M | −$5.67M | −$8.60M |
| Share buybacks | $119.0K | −$309.0K | — | — | $0 | — | — | — |
From Cardlytics's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →